BioCentury | Dec 16, 2013
Strategy

Out in the cold

...testosterone gel Endo Express Scripts ARBs and ARB/diuretic combos (A) Edarbi azilsartan Arbor/Takeda Both Edarbyclor azilsartan medoxomil/...
BioCentury | Sep 23, 2013
Company News

Arbor Pharmaceuticals, Takeda sales and marketing update

...Arbor Pharmaceuticals Ireland Ltd. subsidiary exclusive rights to commercialize hypertension drugs Edarbi azilsartan medoxomil and Edarbyclor azilsartan medoxomil/chlorthalidone...
...royalties. Takeda reported 2012 combined sales of $27 million for the products in the U.S. Edarbi...
BioCentury | Oct 8, 2012
Clinical News

Azilsartan medoxomil regulatory update

...that within the first 8 months of this year, it submitted a regulatory application for azilsartan medoxomil...
...as Edarbi. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Azilsartan medoxomil ( Edarbi ) ( TAK-491...
BioCentury | Oct 8, 2012
Clinical News

Edarbyclor azilsartan medoxomil/chlorthalidone regulatory update

...azilsartan medoxomil/chlorthalidone in Taiwan, Thailand and Indonesia to treat hypertension. Takeda markets the fixed-dose combination of azilsartan medoxomil...
...the EU for Edarbyclor next year. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Edarbyclor azilsartan medoxomil/chlorthalidone...
BioCentury | Feb 13, 2012
Company News

Takeda sales and marketing update

...Takeda launched Edarbyclor azilsartan medoxomil/chlorthalidone in the U.S. to treat hypertension. Edarbyclor is a fixed-dose combination of...
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

...U.S. Simcere Pharmaceutical Group (NYSE:SCR) Iremod iguratimod RA China Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) Edarbi azilsartan medoxomil...
BioCentury | Jan 2, 2012
Clinical News

Edarbyclor azilsartan medoxomil/chlorthalidone regulatory update

...the EU for Edarbyclor in 2013. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Edarbyclor azilsartan medoxomil/chlorthalidone...
BioCentury | Jan 2, 2012
Finance

Small-fry squashed

...with chemotherapy for first-line advanced ovarian cancer Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) EC approves Edarbi azilsartan medoxomil...
BioCentury | Dec 12, 2011
Clinical News

Azilsartan medoxomil regulatory update

...The European Commission approved Edarbi azilsartan medoxomil from Takeda to treat hypertension. Takeda plans to launch the...
...in February. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Azilsartan medoxomil ( Edarbi ) ( TAK-491...
BioCentury | Dec 10, 2011
Company News

EC approves Takeda's Edarbi

...The European Commission approved Edarbi azilsartan medoxomil from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to treat hypertension. Takeda...
Items per page:
1 - 10 of 30